Researchers at the University of Arizona have announced a discovery that may eventually help explain the memory loss associated with Lipitor and other drugs in the popular class of cholesterol-lowering drugs called statins.
A news release from the university notes that physicians and the U.S. Food and Drug Administration continue to document reports of patients experiencing fuzzy thinking and memory loss while taking statins.
The FDA has gone so far as to ...
continue reading...
A clinical study has Australian researchers questioning whether the risks of anti-cholesterol drugs called statins may outweigh the benefits for older patients, according to a report in The Conversation.
According to the report, common side effects from statins such as Lipitor include abdominal pain, nausea, muscle pain and/or weakness, and liver damage.
The U.S. Food and Drug Administration has added warnings to the labels of Lipitor and other ...
continue reading...
A new study has concluded that the class of cholesterol-lowering medications known as statins, which include Lipitor, may put users at greater risk of muscular injury.
A story in The Telegraph quotes researcher Dr. Ishak Mansi of the North Texas Health Care System in Dallas as saying: “Musculoskeletal conditions, arthropathies, injuries and pain are more common among statin users than among similar non-users. The full spectrum of statins’ musculoskeletal adverse events ...
continue reading...
While a recent study by Canadian researchers found a link between certain types of statins and Type 2 diabetes, the news wasn’t universally bad for users of the popular anti-cholesterol drugs.
A story in U.S. News and World Report says the researchers identified stronger statins including Lipitor as problematic.
But other types of statins performed more favorably in terms of diabetes. Study authors wrote that some forms of the drugs may even ...
continue reading...
A new study by Canadian researchers adds to a growing pool of evidence that Lipitor and other types of cholesterol-lowering drugs called statins put patients at a higher risk of developing diabetes.
According to a story on CTV News, researchers published the results of their study in BMJ, a journal of the British Medication Association.
The story notes that previous research has spotlighted a possible link between taking some statins and diabetes, ...
continue reading...
The Wall Street Journal says a dramatic sales drop in Pfizer’s anti-cholesterol medication Lipitor was behind the company’s nine percent revenue decline for the first quarter, which was worse than expected and lowered the company’s full-year outlook.
The U.S. Food and Drug Administration has recently added warnings to the label of Lipitor, advising that the drug may increase the risk of Type II diabetes. The new label also warns that Lipitor ...
continue reading...
